ClinicalTrials.Veeva

Menu

Involvement of Translation Initiation Factors in the Immune Response in the Elderly

Clalit Health Services logo

Clalit Health Services

Status

Unknown

Conditions

Infection
Elderly Patient

Study type

Observational

Funder types

Other

Identifiers

NCT01215604
MMC10156-2010CTIL

Details and patient eligibility

About

The investigators propose that the translation initiation factors eIF4E and eIF4GI may be involved in resolution of acute inflammation (regardless of age). Furthermore, the investigators suggest that differences in translation initiation factors state of activation may contribute to inflammation. Finally, the investigators hypothesize that differences in translation initiation factors state of activation may underlie the immune compromised state of the very elderly affording additional explanation for the heightened morbidity from infection in this group.

In the current study the investigators aim to test these hypotheses by measuring the levels of eIF4E and eIF4G, their regulators, and targets in elderly (65-84yrs) and very elderly (85yrs<) patients hospitalized at Meir hospital for acute infection and after their recovery (detailed in study design).

Enrollment

40 estimated patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • elderly patients (65<)
  • hospitalized for acute infection (fever 38c<, leukocytosis)

Exclusion criteria

  • patients with dementia who can not sign informed consent of institutional Helsinki committee
  • patient with active cancer with active chemotherapy treatment

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems